astx029
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 10, 2018 (NCT03520075)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06284460 | Phase 1/Phase 2 (Phase 2) | Jan 31, 2025 | University of Texas at Houston |
| NCT06113289 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2024 | University of Texas at Houston |
| NCT04466514 | Phase 1 | Jul 23, 2020 | Astex Pharmaceuticals, Inc. |
| NCT03520075 | Phase 1/Phase 2 (Phase 2) | May 10, 2018 | Astex Pharmaceuticals, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astex Pharmaceuticals, Inc. | For profit | 2 | 2 | 2 | 2018 |
| University of Texas at Houston | Academic/Hospital | 2 | 2 | 1 | 2024 |
2 organizations
Page 1 / 1